doi:10.3389/fphar.2020.00805 25
More significantly, MOTS-c administration shifted the trajectory of age-related metabolic decline, indicating that the peptide's benefits are not limited to preventing dysfunction in young animals but can partially reverse established decline [2]
But the story does not end at 68 weeks
Considering the wide exposure to copper and its compounds in our daily life, more information regarding copper compounds on skin toxicity becomes relevant
When exercise is leveraged with GLP-1, the weight loss effect is more substantial, leading to a lower risk of type 2 diabetes and cardiovascular disease
Saxenda still has its place, particularly for adolescents ages 12 and older, where it is the only GLP-1 currently approved